Apoptosis and apoptosis related proteins in chronic viral liver disease

Apoptosis

Volumn 7, Issue 2, 2002, Pages 133-141

  Papakyriakou, P ^a   Tzardi, M ^a   Valatas, V ^a   Kanavaros, P ^a   Karydi, E ^a   Notas, G ^a   Xidakis, C ^a   Kouroumalis, E ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Apoptosis; bcl 2; Chronic viral liver disease; Mdm 2; p21 waf1; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL DAMAGE; LIVER CIRRHOSIS; MONONUCLEAR CELL; NICK END LABELING; PATHOGENESIS; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; VIRUS HEPATITIS;

APOPTOSIS; CHRONIC DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENES, P53; HEPATITIS, VIRAL, HUMAN; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036203442     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014472430976     Document Type: Article

References (58)

1. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis
2. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases
3. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL
4. Liver cell necrosis: Cellular mechanisms and clinical implications
5. Apoptosis A basic biological phenomenon with wide-ranging implications in tissue kinetics
6. Mechanisms of cell death
7. Cytotoxic T cells and viral hepatitis
8. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
9. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
10. Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver
11. Fas antigen expression in liver tissues of patients with chronic hepatitis B
12. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
13. Role of Fas ligand in apoptosis induced by hepatitis C virus infection
14. Serum levels of soluble Fas antigen in chronic hepatitis C patients
15. Increased serum soluble Fas (sFas) concentrations in HCV-positive patients with liver cirrhosis
16. Hepatitis C virus and its pathogenesis
17. Suppression of apoptotic cell death by hepatitis C virus core protein
18. Transcriptional repression of p53 promoter by hepatitis C virus core protein
19. Hepatitis C virus core protein represses p21 WAF1/Cip1/Sid1 promoter activity
20. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis
21. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells
22. Activation of p53 tumor suppressor by hepatitis C virus core protein
23. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability
24. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
25. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation
26. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways
27. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
28. The hepatitis B virus X gene induces p53-mediated programmed cell death
29. Acute and chronic hepatitis revisited. Review by an international group
30. Chronic hepatitis
31. Primary biliary cirrhosis
32. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
33. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
34. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements
35. Activation of protooncogene c-jun by the X protein of hepatitis B virus
36. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level
37. Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product
38. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors
39. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
40. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB
41. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX
42. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
43. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade
44. Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway
45. P53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro
46. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system
47. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note
48. Apoptosis in the failing human heart
49. Ultrastructural and confocal laser scanning microscopic examination of TUNEL-positive cells
50. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
51. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
52. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels
53. Expression of cyclin-dependent kinase inhibitor p21 in human liver
54. Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection
55. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis
56. Immunohistochemical detection of bcl-2 protein in liver lesions: Bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia
57. Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma
58. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression